Schedule 13G ownership disclosure
Precigen Inc
Common Stock · CUSIP: 74017N105
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Patient Capital Management, LLC
Shares: 36,006,800 · Class: 10.2%
- Patient Opportunity Trust, a Series of Advisor Managed Portfolios
Shares: 27,617,612 · Class: 7.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001854794-26-000001
- Form type
- SCHEDULE 13G/A
- Filer
- PRECIGEN, INC.
- CIK
- CIK 1356090
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership